Insights into amyloid disease from fly models

Essays in Biochemistry

Volumn 56, Issue 1, 2014, Pages 69-83

  Chen, Ko Fan ^a   Crowther, Damian C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Drosophila disease model; Motor neuron; Neurodegeneration; Systemic amyloidosis; Tauopathy; Toxic oligomer

Indexed keywords

AMYLOID BETA PROTEIN; DROSOPHILA PROTEIN; TAU PROTEIN;

AMYLOIDOSIS; ANIMAL; DISEASE MODEL; DROSOPHILA MELANOGASTER; HUMAN; METABOLISM; PATHOLOGY;

AMYLOID BETA-PEPTIDES; AMYLOIDOSIS; ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HUMANS; TAU PROTEINS;

EID: 84906260153     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSE0560069     Document Type: Article

References (70)

1. Jacobson, J., Lambert, A.J., Portero-Otín, M., Pamplona, R., Magwere, T., Miwa, S., Driege, Y., Brand, M.D. and Partridge, L. (2010) Biomarkers of aging in Drosophila. Aging Cell 9, 466-477
2. Rogers, I., Kerr, F., Martinez, P., Hardy, J., Lovestone, S. and Partridge, L. (2012) Ageing increases vulnerability to Aß42 toxicity in Drosophila. PLoS ONE 7, e40569
3. Fossgreen, A., Brückner, B., Czech, C., Masters, C.L., Beyreuther, K. and Paro, R. (1998) Transgenic Drosophila expressing human amyloid precursor protein showg-Secretase activity and blistered wing phenotype. Proc. Natl. Acad. Sci. U.S.A. 95, 13703-13708
4. Finelli, A., Kelkar, A., Song, H.J., Yang, H. and Konsolaki, M. (2004) A model for studying Alzheimer's Aß42-Induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 26, 365-375
5. Greeve, I., Kretzschmar, D., Tschape, J.A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R.M. and Reifegerste, R. (2004) Age-Dependent neurodegeneration and Alzheimer-Amyloid plaque formation in transgenic Drosophila. J. Neurosci. 24, 3899-3906
6. Iijima, K., Liu, H.P., Chiang, A.S., Hearn, S.A., Konsolaki, M. and Zhong, Y. (2004) Dissecting the pathological effects of human Aß40 and Aß42 in Drosophila: A potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 6623-6628
7. Crowther, D.C., Kinghorn, K.J., Miranda, E., Page, R., Curry, J.A., Duthie, F.A., Gubb, D.C. and Lomas, D.A. (2005) Intraneuronal Aß, non-Amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132, 123-135
8. Folwell, J., Cowan, C.M., Ubhi, K.K., Shiabh, H., Newman, T.A., Shepherd, D. and Medher, A. (2009) Aß exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp. Neurol. 223, 401-409
9. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714
10. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3ß inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry 9, 522-530
11. Gavin, B.A., Dolph, M.J., Deleault, N.R., Geoghegan, J.C., Khurana, V., Feany, M.B., Dolph, P.J. and Supattapone, S. (2006) Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Straussler-Scheinker syndrome. J. Neurosci. 26, 12408-12414
12. Thackray, A.M., Muhammad, F., Zhang, C., Denyer, M., Spiropoulos, J., Crowther, D.C. and Bujdoso, R. (2012) Prion-Induced toxicity in PrP transgenic Drosophila. Exp. Mol. Pathol. 92, 194-201
13. Feany, M.B. and Bender, W.W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398
14. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-Dependent neurodegeneration in Drosophila. Nature 413, 739-743
15. Karpuj, M.V., Becher, M.W., Springer, J.E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D. and Steinman, L. (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med. 8, 143-149
16. Lagier-Tourenne, C., Polymenidou, M. and Cleveland, D.W. (2010) TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64
17. Lanson, N.A.J., Maltare, A., King, H., Smith, R., Kim, J.H., Taylor, J.P., Lloyd, T.E. and Pandey, U.B. (2011) A Drosophila model of FUS-Related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 20, 2510-2523
18. Jonsson, T., Atwal, J.K., Steinberg, S., Snaedal, J., Jonsson, P.V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J. et al. (2012) A mutation in APP protects against Alzheimer's disease and age-Related cognitive decline. Nature 488, 96-99
19. Berg, I., Nilsson, K.P., Thor, S. and Hammarstrom, P. (2010) Efficient imaging of amyloid deposits in Drosophila models of human amyloidoses. Nat. Protoc. 5, 935-944
20. Iijima, K., Chiang, H.C., Hearn, S.A., Hakker, I., Gatt, A., Shenton, C., Granger, L., Leung, A., Iijima-Ando, K. and Zhong, Y. (2008) Aß42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 3, e1703
21. Luheshi, L.M., Tartaglia, G.G., Brorsson, A.C., Pawar, A.P., Watson, I.E., Chiti, F., Vendruscolo, M., Lomas, D.A., Dobson, C.M. and Crowther, D.C. (2007) Systematic in vivo analysis of the intrinsic determinants of amyloid ß pathogenicity. PLoS Biol. 5, e290
22. Brorsson, A.C., Bolognesi, B., Tartaglia, G.G., Shammas, S.L., Favrin, G., Watson, I., Lomas, D.A., Chiti, F., Vendruscolo, M., Dobson, C.M. et al. (201) Intrinsic determinants of neurotoxic aggregate formation by the amyloid ß peptide. Biophys. J. 98, 1677-1684
23. Speretta, E., Jahn, T.R., Tartaglia, G.G., Favrin, G., Barros, T.P., Imarisio, S., Lomas, D.A., Luheshi, L.M., Crowther, D.C. and Dobson, C.M. (2012) Expression in Drosophila of tandem amyloid beta peptides provides insights into links between aggregation and neurotoxicity. J. Biol. Chem. 287, 20748-20754
24. Cao, W., Song, H.J., Gangi, T., Kelkar, A., Antani, I., Garza, D. and Konsolaki, M. (2008) Identification of novel genes that modify phenotypes induced by Alzheimer's ß-Amyloid overexpression in Drosophila. Genetics 178, 1457-1471
25. Rival, T., Page, R.M., Chandraratna, D.S., Sendall, T.J., Ryder, E., Liu, B., Lewis, H., Rosahl, T., Hider, R., Camargo, L.M. et al. (2009) Fenton chemistry and oxidative stress mediate the toxicity of the ß-Amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 29, 1335-1347
26. 42 induced neurotoxicity. Int. J. Alzheimers Dis. 2013, 567128
27. 42-Induced Alzheimer's disease-Like symptoms. Neurobiol. Aging 34, 2604-2612
28. Liu, B., Moloney, A., Meehan, S., Morris, K., Thomas, S.E., Serpell, L.C., Hider, R., Marciniak, S.J., Lomas, D.A. and Crowther, D.C. (2011) Iron promotes the toxicity of amyloid ß peptide by impeding its ordered aggregation. J. Biol. Chem. 286, 4248-4256
29. Goedert, M. and Spillantini, M.G. (2000) Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta 1502, 110-121
30. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-Type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519
31. Shulman, J.M. and Feany, M.B. (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165, 1233-1242
32. Blard, O., Feuillette, S., Bou, J., Chaumette, B., Frebourg, T., Campion, D. and Lecourtois, M. (2007) Cytoskeleton proteins are modulators of mutant tau-Induced neurodegeneration in Drosophila. Hum. Mol. Genet. 16, 555-566
33. Fulga, T.A., Elson-Schwab, I., Khurana, V., Steinhilb, M.L., Spires, T.L., Hyman, B.T. and Feany, M.B. (2007) Abnormal bundling and accumulation of F-Actin mediates tau-Induced neuronal degeneration in vivo. Nat. Cell Biol. 9, 139-148
34. Shulman, J.M., Imboywa, S., Giagtzoglou, N., Powers, M.P., Hu, Y., Devenport, D., Chipendo, P., Chibnik, L.B., Diamond, A., Perrimon, N. et al. (2014) Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-Mediated mechanisms. Hum. Mol. Genet. 23, 870-877
35. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Carrasquillo, M.M., Abraham, R., Hamshere, M.L., Pahwa, J.S., Moskvina, V. et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435
36. Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., Jun, G., DeStefano, A.L., Bis, J.C., Beecham, G.W. et al. (2013) Meta-Analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 45, 1452-1458
37. Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K.V., Geller, F., Sottejeau, Y., Harold, D., Dourlen, P. et al. (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol. Psychiatry 18, 1225-1234
38. Steinhilb, M.L., Dias-Santagata, D., Mulkearns, E.E., Shulman, J.M., Biernat, J., Mandelkow, E.M. and Feany, M.B. (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res. 85, 1271-1278
39. Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.M. and Mandelkow, E. (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-Associated proteins and trigger microtubule disruption. Cell 89, 297-308
40. Trinczek, B., Brajenovic, M., Ebneth, A. and Drewes, G. (2003) MARK4 is a novel microtubule-Associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. J. Biol. Chem. 279, 5915-5923
41. Nishimura, I., Yang, Y., Lu, B. (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116, 671-682
42. Steinhilb, M.L., Dias-Santagata, D., Fulga, T.A., Felch, D.L. and Feany, M.B. (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell 18, 5060-5068
43. Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B. and Iijima, K.M. (2012) Loss of axonal mitochondria promotes tau-Mediated neurodegeneration and Alzheimer's disease-Related tau phosphorylation via PAR-1. PLoS Genet. 8, e1002918
44. Tare, M., Modi, R.M., Nainaparampil, J.J., Puli, O.R., Bedi, S., Fernandez-Funez, P., Kango-Singh, M. and Singh, A. (2011) Activation of JNK signaling mediates amyloid-ß-Dependent cell death. PLoS ONE 6, e24361
45. Hong, Y.K., Lee, S., Park, S.H., Lee, J.H., Han, S.Y., Kim, S.T., Jeon, S., Koo, B.S. and Cho, K.S. (2012) Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model. Biochem. Biophys. Res. Commun. 419, 49-53
46. 262phosphorylation is critical for Aß42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Hum. Mol. Genet. 19, 2947-2957
47. Gurlo, T., Ryazantsev, S., Huang, C.J., Yeh, M.W., Reber, H.A., Hines, O.J., O'Brien, T.D., Glabe, C.G. and Butler, P.C. (2010) Evidence for proteotoxicity in ß cells in Type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am. J. Pathol. 176, 861-869
48. Betsholtz, C., Christmansson, L., Engstrom, U., Rorsman, F., Svensson, V., Johnson, K.H. and Westermark, P. (1989) Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 251, 261-264
49. Schultz, S.W., Nilsson, K.P. and Westermark, G.T. (2011) Drosophila melanogaster as a model system for studies of islet amyloid polypeptide aggregation. PLoS ONE 6, e20221
50. Paulsson, J.F. and Westermark, G.T. (2005) Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 54, 2117-2125
51. Marzban, L., Rhodes, C.J., Steiner, D.F., Haataja, L., Halban, P.A. and Verchere, C.B. (2006) Impaired NH2-Terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55, 2192-2201
52. Pepys, M.B. (2006) Amyloidosis. Annu. Rev. Med. 57, 223-241
53. Picken, M.M. (2010) Amyloidosis-Where are we now and where are we heading? Arch. Pathol. Lab. Med. 134, 545-551
54. Cornwell, G.G., Murdoch, W.L., Kyle, R.A., Westermark, P. and Pitkanen, P. (1983) Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am. J. Med. 75, 618-623
55. Dharmarajan, K. and Maurer, M.S. (2012) Transthyretin cardiac amyloidoses in older North Americans. J. Am. Geriatr. Soc. 60, 765-774
56. Regel, R., Matioli, S.R. and Terra, W.R. (1998) Molecular adaptation of Drosophila melanogaster lysozymes to a digestive function. Insect Biochem. Mol. Biol. 28, 309-319
57. Pepys, M.B., Hawkins, P.N., Booth, D.R., Vigushin, D.M., Tennent, G.A., Soutar, A.K., Totty, N., Nguyen, O., Blake, C.C., Terry, C.J. et al. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362, 553-557
58. Yazaki, M., Farrell, S.A. and Benson, M.D. (2003) A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int. 63, 1652-1657
59. Kumita, J.R., Helmfors, L., Williams, J., Luheshi, L.M., Menzer, L., Dumoulin, M., Lomas, D.A., Crowther, D.C., Dobson, C.M. and Brorsson, A.C. (2011) Disease-Related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster. FASEB J. 26, 192-202
60. Kumita, J.R., Johnson, R.J., Alcocer, M.J., Dumoulin, M., Holmqvist, F., McCammon, M.G., Robinson, C.V., Archer, D.B. and Dobson, C.M. (2006) Impact of the native-State stability of human lysozyme variants on protein secretion by Pichia pastoris. FEBS J. 273, 711-720
61. Whyteside, G., Alcocer, M.J., Kumita, J.R., Dobson, C.M., Lazarou, M., Pleass, R.J. and Archer, D.B. (2011) Native-State stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris. PLoS ONE 6, e22692
62. Paggiaro, P.L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., Efthimiou, J. (1998) Multicentre randomised placebo-Controlled trial of inhaled fluticasone proprionate in patients with chronic obstructive pulmonary disease. Lancet 351, 773-780
63. Yi, S., Takahashi, K., Naito, M., Tashiro, F., Wakasugi, S., Maeda, S., Shimada, K., Yamamura, K. and Araki, S. (1991) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am. J. Pathol. 138, 403-412
64. Araki, S., Yi, S., Murakami, T., Watanabe, S., Ikegawa, S., Takahashi, K. and Yamarnura, K. (1994) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I. Mol. Neurobiol. 8, 15-23
65. Sousa, M.M., Fernandes, R., Palha, J.A., Taboada, A., Vieira, P. and Saraiva, M.J. (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am. J. Pathol. 161, 1935-1948
66. Pokrzywa, M., Dacklin, I., Hultmark, D. and Lundgren, E. (2007) Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-Associated amyloidosis. Eur. J. Neurosci. 26, 913-924
67. Pokrzywa, M., Dacklin, I., Vestling, M., Hultmark, D., Lundgren, E. and Cantera, R. (2010) Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-Associated amyloidosis. PLoS ONE 5, e14343
68. Andersson, K., Pokrzywa, M., Dacklin, I. and Lundgren, E. (2013) Inhibition of TTR aggregation-Induced cell death: A new role for serum amyloid P component. PLoS ONE 8, e55766
69. Noborn, F., O'Callaghan, P., Hermansson, E., Zhang, X., Ancsin, J.B., Damas, A.M., Dacklin, I., Presto, J., Johansson, J., Saraiva, M.J. et al. (2011) Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proc. Natl. Acad. Sci. U.S.A. 108, 5584-5589
70. Stine, Jr, W.B., Dahlgren, K.N., Krafft, G.A. and LaDu, M.J. (2003) In vitro characterization of conditions for amyloid-ß peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622